Märten A - Search Results

1

Effect of Flt3 ligand gene transfer in experimental pancreatic cancer.

Ryschich E, Huszty G, Wentzensen N, Schmidt E, Knaebel HP, Encke J, Märten A, Büchler MW, Schmidt J. Ryschich E, et al. Among authors: marten a. Int J Colorectal Dis. 2007 Feb;22(2):215-23. doi: 10.1007/s00384-006-0118-5. Epub 2006 Mar 10. Int J Colorectal Dis. 2007. PMID: 16528542

2

Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma.

Schmidt J, Eisold S, Büchler MW, Märten A. Schmidt J, et al. Among authors: marten a. Cancer Immunol Immunother. 2004 Nov;53(11):1018-26. doi: 10.1007/s00262-004-0554-4. Epub 2004 Jun 5. Cancer Immunol Immunother. 2004. PMID: 15185013 Free PMC article.

3

Telomerase-specific T-cells kill pancreatic tumor cells in vitro and in vivo.

Schmidt J, Ryschich E, Sievers E, Schmidt-Wolf IG, Büchler MW, Märten A. Schmidt J, et al. Among authors: marten a. Cancer. 2006 Feb 15;106(4):759-64. doi: 10.1002/cncr.21655. Cancer. 2006. PMID: 16369992 Free article.

4

Immunomodulatory impact of interferon-alpha in combination with chemoradiation of pancreatic adenocarcinoma (CapRI).

Schmidt J, Patrut EM, Ma J, Jäger D, Knaebel HP, Büchler MW, Märten A. Schmidt J, et al. Among authors: marten a. Cancer Immunol Immunother. 2006 Nov;55(11):1396-405. doi: 10.1007/s00262-006-0140-z. Epub 2006 Feb 17. Cancer Immunol Immunother. 2006. PMID: 16485127 Free PMC article.

5

Activating anti-CD40 antibodies induce tumour invasion by cytotoxic T-lymphocytes and inhibition of tumour growth in experimental liver cancer.

Ryschich E, Märten A, Schmidt E, Linnebacher M, Wentzensen N, Eisold S, Klar E, Büchler MW, Schmidt J. Ryschich E, et al. Among authors: marten a. Eur J Cancer. 2006 May;42(7):981-7. doi: 10.1016/j.ejca.2006.01.024. Epub 2006 Mar 27. Eur J Cancer. 2006. PMID: 16564167

6

Transfection with CD40L induces tumour suppression by dendritic cell activation in an orthotopic mouse model of pancreatic adenocarcinoma.

Serba S, Schmidt J, Wentzensen N, Ryschich E, Märten A. Serba S, et al. Among authors: marten a. Gut. 2008 Mar;57(3):344-51. doi: 10.1136/gut.2007.130252. Epub 2007 Aug 3. Gut. 2008. PMID: 17675324

7

Synergistic effects of interferon-alpha in combination with chemoradiation on human pancreatic adenocarcinoma.

Ma JH, Patrut E, Schmidt J, Knaebel HP, Büchler MW, Märten A. Ma JH, et al. Among authors: marten a. World J Gastroenterol. 2005 Mar 14;11(10):1521-8. doi: 10.3748/wjg.v11.i10.1521. World J Gastroenterol. 2005. PMID: 15770730 Free PMC article.

8

Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivo.

Schmidt J, Klempp C, Büchler MW, Märten A. Schmidt J, et al. Among authors: marten a. Cancer Immunol Immunother. 2006 Jan;55(1):31-8. doi: 10.1007/s00262-005-0690-5. Epub 2005 Oct 27. Cancer Immunol Immunother. 2006. PMID: 15891882 Free PMC article.

9

Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicity.

Märten A, von Lilienfeld-Toal M, Büchler MW, Schmidt J. Märten A, et al. Int J Cancer. 2006 Nov 15;119(10):2359-65. doi: 10.1002/ijc.22186. Int J Cancer. 2006. PMID: 16929491

10

Impact of interferon-alpha in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): first data from the immunomonitoring.

Schmidt J, Jäger D, Hoffmann K, Büchler MW, Märten A. Schmidt J, et al. Among authors: marten a. J Immunother. 2007 Jan;30(1):108-15. doi: 10.1097/01.cji.0000211317.15278.27. J Immunother. 2007. PMID: 17198089 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters